Logo

American Heart Association

Jason Ta

Is this you? Login and claim your profile. Then, you can add your biography and additional Information.

Showing 1 Abstract.

Meta-Analysis of Phase III Randomized Controlled Trials to Evaluate the Risk of Cardiac Adverse Events in Patients with Non-small Cell Lung Cancer Treated with Osimertinib Compared to Control

Meeting name: Scientific Sessions 2025 , 2025 , New Orleans, Louisiana

Authors: Win Zin, Hussain Abbas, Srinivasmurthy Ramaditya, Hattin Riccesha, Jones Daniel, Nanda Rishi, Ta Jason, Chu Timothy, Tun Tin, Aboaid Hazem, Nguyen Kevin, Myat Yin, Chu Matthew, Mohib Khadija, Macias Aziel, Htwe Khaing Khaing, Thein Kyaw

Keywords: Cardio-oncology, QT interval, Heart failure, Ejection fraction, Quality of life